Partnership to accelerate adoption of SigTuple’s AI100 across the Indian subcontinent
HORIBA, medical diagnostic company and SigTuple, a medtech company that develops AI-powered digital microscopy solutions has announced a partnership to accelerate adoption of SigTuple’s AI100 across the Indian subcontinent.
SigTuple leverages AI & robotics, to automate the error prone and inefficient manual microscopic review of samples in laboratories. SigTuple’s AI100 is the AI-assisted digital pathology solution. Its AI based cell classification is presented to a pathologist on a cloud platform, standardising the quality and increasing the efficiency of the pathologist multifold. Further, showcasing the microscopic view of the slide remotely, drives seamless transition from manual microscopy to digital microscopy and enables tele-pathology. AI100 is complementary to HORIBA’s existing product portfolio and through this partnership, HORIBA and its affiliates will distribute AI100 across the Indian subcontinent.
SigTuple’s AI100 currently automates the microscopic review of the two most common tests coming to the lab – peripheral blood smear and urine, with plans to add AI capabilities for more tests on the same platform. The peripheral blood smear review is a powerful and essential diagnostic tool that provides clinicians information about a variety of diseases such as blood related cancers, anaemia, viral & bacterial infections, haematological disorders and many other life-threatening medical conditions.